Home›People›Alessandra Di Bacco
AB

Alessandra Di Bacco

Director at EvolveImmune Therapeutics Holding Company.

Director
Updated Nov 15, 2026·Latest SEC filing Nov 16, 2023·Suggest an edit

About Alessandra Di Bacco

Form D filings for EvolveImmune Therapeutics Holding Company from 2020 to 2023 list Alessandra Di Bacco as director.

Alessandra Di Bacco first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Alessandra Di Bacco in the role, so the role may have started earlier or lasted longer.

EvolveImmune Therapeutics Holding Company, LLC
Director
2020 – 2023 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.

Key Colleagues at Startups

The people Alessandra Di Bacco works with at each company, as listed on that company's latest Form D.

DP
DY
Derek Yoon
Director
IT
Ian Taylor
Director
SB
Stephen Bloch
Co-founder and Chief Executive Officer, director

Sources

  1. SECEvolveImmune Therapeutics Holding Company, LLC Form D, filed Nov 16, 2023